Table 1 Demographic and clinical characteristics of participants at baseline assessment (n = 17)
Characteristics | Â | Â |
|---|---|---|
Demographic | Â | Â |
Age at baseline, mean (SD) | 60 (8) | |
| Â | N | % |
Marital status | Â | Â |
   Never married | 3 | 18 |
   De facto/married | 10 | 58 |
   Separated/divorced | 3 | 18 |
   Widowed | 1 | 6 |
Education level | Â | Â |
   University | 2 | 12 |
   Technical/trade | 2 | 12 |
   Secondary (grade 10-12) | 13 | 76 |
Private health insurance | Â | Â |
   No | 13 | 76 |
   Yes | 4 | 24 |
Body mass index categories* | Â | Â |
   Underweight (< 18.5 kg/m2) | 2 | 20 |
   Healthy weight (18.5-24.9 kg/m2) | 4 | 40 |
   Overweight (25-29.9 kg/m2) | 2 | 20 |
   Obese (30+ kg/m2) | 2 | 20 |
Clinical | Â | Â |
Primary cancer site | Â | Â |
   Ovary | 13 | 76 |
   Peritoneum | 4 | 24 |
Histology | Â | Â |
   Endometrioid | 1 | 6 |
   Serous and other | 14 | 82 |
   Mucinous | 1 | 6 |
   Unknown | 1 | 6 |
Disease stage (FIGO) | Â | Â |
   I | 1 | 6 |
   II | 1 | 6 |
   III | 11 | 64 |
   IV | 4 | 24 |
Chemotherapy regimen | Â | Â |
   6 × 3-weekly Carboplatin + Paclitaxel | 10 | 59 |
   Other | 7 | 41 |
Chemotherapy route | Â | Â |
   Intravenous | 9 | 53 |
   Intravenous + Intraperitoneal | 8 | 47 |
Chemotherapy course | Â | Â |
   Adjuvant | 14 | 82 |
   Neo-adjuvant | 3 | 18 |